万润股份(002643):九目化学北交所IPO申请获正式受理,2025年前三季度归母净利润同比增长:——万润股份(002643):2025年三季报点评

Investment Rating - The investment rating for the company is "Buy" (maintained) [2][13][14] Core Views - The company achieved a revenue of 2.826 billion yuan in the first three quarters of 2025, representing a year-on-year increase of 2.31%. The net profit attributable to the parent company was 306 million yuan, up 3.27% year-on-year, while the net profit after deducting non-recurring gains and losses was 292 million yuan, reflecting a 14.02% increase year-on-year [6][8][12] - The company is focusing on advanced materials research and development, aiming to become a world-class chemical materials manufacturer. Recent projects include the expansion of production capacity for photoresists and polyimides, with significant investments planned [11][12] - The company has seen a reduction in expense ratios, contributing to the growth in net profit for the first three quarters of 2025 [8][9] Summary by Sections Financial Performance - In Q3 2025, the company reported a revenue of 956 million yuan, a year-on-year increase of 18.62%, but a quarter-on-quarter decrease of 5.19%. The net profit attributable to the parent company was 87 million yuan, up 8.41% year-on-year but down 36.75% quarter-on-quarter [7][9] - The gross profit margin for Q3 2025 was 40.06%, an increase of 0.39 percentage points year-on-year and 0.29 percentage points quarter-on-quarter [7][9] Cost Management - The company reported a sales expense ratio of 3.13%, a decrease of 0.23 percentage points year-on-year. The management expense ratio was 9.20%, down 0.52 percentage points year-on-year, and the R&D expense ratio was 10.99%, down 0.20 percentage points year-on-year [8][9] Future Outlook - The company forecasts revenues of 3.884 billion yuan, 4.460 billion yuan, and 5.328 billion yuan for 2025, 2026, and 2027, respectively. The net profit attributable to the parent company is expected to be 402 million yuan, 490 million yuan, and 586 million yuan for the same years [12][13]